eMedicine Specialties > Pediatrics: Surgery > Otolaryngology

Hearing Impairment: Treatment & Medication

Author: Rahul K Shah, MD, FAAP, Assistant Professor of Otolaryngology and Pediatrics, George Washington University, Children's National Medical Center; Attending Physician, Department of Otolaryngology, Children's National Medical Center
Coauthor(s): Michael Lotke, MD, Pediatric Residency Program Director, Mount Sinai Hospital; Assistant Professor, Department of Pediatrics, Rosalind Franklin University of Medicine and Science
Contributor Information and Disclosures

Updated: Jul 21, 2008

Treatment

Medical Care

Treatment for CHL

Manage CHL due to otitis media or its sequelae with a course of appropriate antibiotics. A patient with a serous otitis media for longer than 3 months benefit from myringotomy and removal of the fluid in the middle ear. Ventilation tubes may ultimately be necessary. If the hearing loss continues, amplification with a hearing aid may be needed. Speech therapy is rarely necessary unless the loss is prolonged and cannot be corrected with amplification.

CHL that results from obstruction of the auditory canal because of cerumen or a foreign body should be treated by removing the obstruction.

Treatment for SNHL

SNHL cannot be medically treated.6 Amplification with hearing aids is used to give the child as much auditory input as possible. Speech therapy may be beneficial. If the child requires special schooling, the program determines how much speech training is routinely part of the school day. Preferential seating and use of FM systems should be discussed with the patient's family and teachers.

In older children and in adults, goals for amplification may be as much as 40-60 dB or whatever achieves a nominal hearing level. The limiting factor is the physical sound pressure exerted on the tympanic membrane, which becomes painful after a certain threshold. Young children with small ear canals perceive pain at amplification volumes as low as 10-15 dB. Modern hearing aids can selectively amplify a specified range of frequencies more than others rather than all frequencies equally.

After the hearing aid is fitted by using proper molds, the hearing aid is tested to see how well it matches the goals for loudness at various frequencies. With an older child, speech recognition can be part of this testing. For a young child, the most important goal is to optimize auditory input without causing pain, which can cause the child to avoid using the hearing aid.

Young children should use their hearing aids because the stimulus helps to connect them to their environment and because it maximizes auditory language development. Older children may choose not to use their hearing aids. Parents should be reasonable. For example, if their child is succeeding in school, the hearing aids may not offer a substantial language benefit. If the child prefer not to wear the hearing aids after school, parents should respect this decision.

No medical disadvantage occurs if children choose to not use hearing aids. In fact, many deaf adults use their hearing aids selectively or not at all because they find that the extraneous noises and distortions they hear are more bothersome than helpful. They may use their hearing aids only when they anticipate a particular benefit.

Surgical Care

Some causes of CHL may be managed or aided surgically.

Children with persistent chronic or recurrent otitis media with resultant effusions may benefit from the placement of myringotomy tubes to ventilate the middle-ear space to prevent negative pressure in this area. If otitis results in the destruction or fixation of the ossicles, surgery may improve ossicular function.

Cholesteatoma is a surgical disease.

Bone-anchored hearing aids (BAHAs) may be useful in some patients. Examples are patients with microtia, those with anotia who are awaiting auricular reconstruction, and patients with persistent otorrhea who cannot use a hearing aid.

SNHL cannot be treated with surgical means other than cochlear implantation. Cochlear implantation may be an option in some children, but it should not be mistaken for a cure. Cochlear implants are discussed in the Cochlear implants section below.

Consultations

  • Otolaryngologist: Consulting an otolaryngologist is imperative if the child has CHL. An otolaryngologist can provide advice pertaining to medical and potential surgical interventions. Consultation is also recommended if the child has profound SNHL and is a potential candidate for cochlear implants. The otolaryngologist is a crucial member of the multidisciplinary team needed to help patients with profound SNHL.
  • Specialists in early intervention: Early intervention programs are essential to help parents understand how to raise a deaf child or one hard of hearing. Such programs are also needed to begin discussing and implementing language and/or educational programs.
  • Audiologist: Consulting an audiologist is essential for evaluating patients for hearing aids and for fitting them.
  • Geneticist: Consultation with a geneticist is recommended if the cause of deafness may be syndromic or if the family history suggests a hereditary pattern.
  • Ophthalmologist, nephrologist, cardiologist: Consulting these subspecialists is recommended if an identifiable syndrome implicates involvement of the visual, renal, or cardiac organ system or if involvement of an organ system is suspected because a particular syndrome is or may be present.
  • Experts in managing hearing loss: Consult physicians with expertise in caring for patients with hearing loss. Some physicians have developed expertise in the field of deafness and may be available for consultation. They can offer information about associated medical conditions if present, as well as perspective about language and education, use of  hearing aids and cochlear implants, and other equipment. The literature is filled with debates about the most appropriate venues for children who are deaf or hard of hearing. Many people involved in early intervention are affiliated with a particular program because it matches their personal biases. Physicians with expertise in deafness may be neutral.

Medication

No medical therapy is specifically available for deafness. Only some etiologies of CHL may be managed medically.

More on Hearing Impairment

Overview: Hearing Impairment
Differential Diagnoses & Workup: Hearing Impairment
Treatment & Medication: Hearing Impairment
Follow-up: Hearing Impairment
References

References

  1. Erenberg A, Lemons J, Sia C, Trunkel D, Ziring P. Newborn and infant hearing loss: detection and intervention.American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998- 1999. Pediatrics. Feb 1999;103(2):527-30. [Medline].

  2. Richardson SO. The child with "delayed speech". Contemp Pediatr. 1992;9(9):55.

  3. Parry DA, Booth T, Roland PS. Advantages of magnetic resonance imaging over computed tomography in preoperative evaluation of pediatric cochlear implant candidates. Otol Neurotol. Sep 2005;26(5):976-82. [Medline].

  4. Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics. Oct 2007;120(4):898-921. [Medline].

  5. Berlin CI, Morlet T, Hood LJ. Auditory neuropathy/dyssynchrony: its diagnosis and management. Pediatr Clin North Am. Apr 2003;50(2):331-40, vii-viii. [Medline].

  6. Brookhouser PE, Beauchaine KL, Osberger MJ. Management of the child with sensorineural hearing loss. Medical, surgical, hearing aids, cochlear implants. Pediatr Clin North Am. Feb 1999;46(1):121-41. [Medline].

  7. American Academy of Pediatrics Joint Committee on Infant Hearing. Joint Committee on Infant Hearing 1994 Position Statement. Pediatrics. Jan 1995;95(1):152-6. [Medline].

  8. Horn RM, Nozza RJ, Dolitsky JN. Audiological and medical considerations for children with cochlear implants. Am Ann Deaf. Apr 1991;136(2):82-6. [Medline].

  9. Annual Survey of Hearing-Impaired Children and Youth. Characteristics of deaf and hard-of-hearing students in four special education program types. Annual Survey of Hearing-Impaired Children and Youth 1992-1993. Am Ann Deaf. 1994;139(2):242.

  10. Berlin CI. Role of infant hearing screening in health care. Semin Hearing. 1996;17(2):115.

  11. Finitzo T, Crumley WG. The role of the pediatrician in hearing loss. From detection to connection. Pediatr Clin North Am. Feb 1999;46(1):15-34, ix-x. [Medline].

  12. Freeman RD, Carbin CF, Boese RJ. Can't your child hear?. In: A Guide for Those Who Care About Deaf Children. Baltimore, Md: University Park; 1981.

  13. Glossack ME, McKennan KX, Levine SC. Differential diagnosis of sensorineural hearing loss in children. In: Bess FH, ed. Hearing Impairment in Children. Parkton, MD: York; 1988:347-374.

  14. Harvell JD, Williford PL, White WL. Benign cutaneous Degos' disease: a case report with emphasis on histopathology as papules chronologically evolve. Am J Dermatopathol. Apr 2001;23(2):116-23. [Medline].

  15. Marazita ML, Ploughman LM, Rawlings B, et al. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet. Jun 15 1993;46(5):486-91. [Medline].

  16. McEwen E, Anton-Culver H. The medical communication of deaf patients. J Fam Pract. Mar 1988;26(3):289-91. [Medline].

  17. Meadow KP, Trybus RJ. Behavioral and emotional problems of deaf children: an overview. In: Bradford LJ, Hardy WG, eds. Hearing and Hearing Impairment. New York, NY: Grune and Stratton; 1979.

  18. Meadow-Orlans KP. An analysis of the effectiveness of early intervention programs for hearing-impaired children. In: Guralnick M, Bennett F, eds. The Effectiveness of Early Intervention for At-risk and Handicapped Children. New York, NY: Academic; 1987:326-362.

  19. Montgomery GW. The relationship of oral skills to manual communication in profoundly deaf adolescents. Am Ann Deaf. 1966;111:557.

  20. Morton CC, Nance WE. Newborn hearing screening--a silent revolution. N Engl J Med. May 18 2006;354(20):2151-64. [Medline].

  21. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci. 1991;630:16-31. [Medline].

  22. National Institutes of Health. National Institutes of Health Consensus Development Conference Statement. Early identification of hearing impairment in infants and young children. Int J Pediatr Otorhinolaryngol. Oct 1993;27(3):215-27. [Medline].

  23. Nikolopoulos TP, Lioumi D, Stamataki S, O'Donoghue GM. Evidence-based overview of ophthalmic disorders in deaf children: a literature update. Otol Neurotol. Feb 2006;27(2 Suppl 1):S1-24, discussion S20. [Medline].

  24. Northern JL, Downs MP. Hearing in Children. Baltimore, Md: Lippincott Williams & Wilkins; 1974.

  25. Power DJ, Hyde MB. The cochlear implant and the deaf community. Med J Aust. Sep 21 1992;157(6):421-2. [Medline].

  26. Roizen NJ. Etiology of hearing loss in children. Nongenetic causes. Pediatr Clin North Am. Feb 1999;46(1):49-64, x. [Medline].

  27. Schein JD, Delk MT. The Deaf Population of the United States. Silver Spring, Md: National Association of the Deaf; 1971.

  28. Shroyer EH. Signs of the Times. Washington, DC: Gallaudet University Press; 1982.

  29. Stein LK. Factors influencing the efficacy of universal newborn hearing screening. Pediatr Clin North Am. Feb 1999;46(1):95-105. [Medline].

  30. Stuckless ER, Birch JW. The influence of early manual communication on the linguistic development of deaf children. Am Ann Deaf. 1966;111:452.

  31. Tomaski SM, Grundfast KM. A stepwise approach to the diagnosis and treatment of hereditary hearing loss. Pediatr Clin North Am. Feb 1999;46(1):35-48. [Medline].

  32. Twefik TL, Teebi AS, Der Kaloustian VM. Syndromes and conditions associated with genetic deafness. In: Twefik TL, Der Kaloustian VM, eds. Congenital Anomalies of the Ear, Nose, and Throat. Oxford, England: Oxford University Press; 1997.

  33. Watkins S. Long term effects of home intervention with hearing-impaired children. Am Ann Deaf. Oct 1987;132(4):267-71. [Medline].

Further Reading

Keywords

hearing loss, deaf, deafness, hard of hearing, hard-of-hearing, conductive hearing loss, CHL, sensorineural hearing loss, SNHL, mixed hearing loss, American Sign Language, ASL, English Sign Language, Signed English, SE, Signing Exact English/Seeing Essential English, SEE, Signing Exact English, SEE 1, Seeing Essential English, SEE 2, lip-reading, lipreading, lip reading, total communication, voice and sign language, brainstem audio-evoked response, BAER, automated auditory brainstem response, ABR, AABR, otoacoustic emissions, OAEs, audiometry, otosclerosis

cholesteatoma, glomus tympanicum, glomus jugulare, schwannomas of the facial nerve, hemangiomas, encephalocele, Waardenburg syndrome, Gernet syndrome, Winter syndrome, Rosenberg syndrome, Turner syndrome, Klinefelter syndrome, DiGeorge syndrome, Townes-Brocks syndrome, Miller syndrome, Bixler syndrome, coloboma, heart disease, atresia choanae, retarded growth, ear anomalies, CHARGE syndrome, Jervell Lange-Nielson syndrome, limb-oto-cardiac syndrome, Alport syndrome, branchio-oto-renal syndrome, Kearns-Sayre syndrome

Epstein syndrome, Barakat syndrome, Killian/Teschler-Nicola syndrome, Noonan syndrome, Cockayne syndrome, Gustavson syndrome, LEOPARD syndrome, Senter syndrome, BADS syndrome, Davenport syndrome, Pendred syndrome, Johanson-Blizzard syndrome, Refetoff syndrome, Wolfram syndrome, Kallmann syndrome, Goldenhar syndrome, frontometaphyseal dysplasia, Escher-Hirt syndrome, Levy-Hollister syndrome, Usher syndrome, Marshall syndrome, Harboyan syndrome, Fraser syndrome, Jensen syndrome, craniometaphyseal dysplasia, OSMED syndrome, cytomegalovirus, CMV, herpes, rubella, syphilis, toxoplasmosis, varicella, meningitis, mumps

Contributor Information and Disclosures

Author

Rahul K Shah, MD, FAAP, Assistant Professor of Otolaryngology and Pediatrics, George Washington University, Children's National Medical Center; Attending Physician, Department of Otolaryngology, Children's National Medical Center
Rahul K Shah, MD, FAAP is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, Massachusetts Medical Society, Phi Beta Kappa, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society
Disclosure: Nothing to disclose.

Coauthor(s)

Michael Lotke, MD, Pediatric Residency Program Director, Mount Sinai Hospital; Assistant Professor, Department of Pediatrics, Rosalind Franklin University of Medicine and Science
Michael Lotke, MD is a member of the following medical societies: American Academy of Pediatrics and American Public Health Association
Disclosure: Nothing to disclose.

Medical Editor

Orval Brown, MD, Director of Otolaryngology Clinic, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center at Dallas
Orval Brown, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Medical Association, American Society of Pediatric Otolaryngology, Society for Ear, Nose and Throat Advances in Children, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

John E McClay, MD, Assistant Professor, Department of Otolaryngology, Division of Pediatric Otolaryngology, Children's Medical Center, University of Texas Southwestern Medical School
John E McClay, MD is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Medical Association
Disclosure: Nothing to disclose.

CME Editor

Paul D Petry, DO, FACOP, FAAP, Consulting Staff, Freeman Pediatric Care, Freeman Health System
Paul D Petry, DO, FACOP, FAAP is a member of the following medical societies: American Academy of Osteopathy, American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association
Disclosure: Nothing to disclose.

Chief Editor

Maureen Strafford, MD, Arnold P Gold Foundation Associate Professor, Departments of Anesthesiology and Pediatrics, Tufts University and Tufts-New England Medical Center
Maureen Strafford, MD is a member of the following medical societies: American Medical Women's Association, American Pain Society, American Society of Anesthesiologists, International Anesthesia Research Society, Society for Education in Anesthesia, Society for Pediatric Anesthesia, and Society of Cardiovascular Anesthesiologists
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.